Results 71 to 80 of about 171,828 (231)

Adenocarcinoma in the distal esophagus with and without Barrett esophagus. Differences in symptoms and survival rates

, 1996
OBJECTIVE: To evaluate differences in clinical appearance and survival rates in patients operated on for adenocarcinoma in the distal esophagus with and without Barrett epithelium.DESIGN: Prospective clinical study.SETTING: University hospital, Sweden ...
Staël von Holstein, C, Zilling, T, Johnsson, F, Johansson, J, Willén, R, Walther, B   +5 more
core   +1 more source

Diagnostic impact and reproducibility of p53 immunohistochemistry in Barrett's oesophagus: results of the Dutch Esophageal Pathology Panel (DEPP)

Histopathology, Volume 89, Issue 4, Page 614-623, October 2026.
Structured p53‐IHC in Barrett's oesophagus supports diagnostic decision‐making. In 1,146 cases, agreement between referring hospitals and the expert panel was moderate‐to‐substantial (κ = 0.61), with 24.2% of p53‐based classifications revised. Interobserver agreement among expert pathologists was substantial (κ = 0.65).
Ylva A. Weeda, Sarah M. Issa, Hans Halfwerk, Michel Botros, Onno J. de Boer, Lodewijk A. Brosens, Michail Doukas, Gursah Kats‐Ugurlu, Fiebo ten Kate, Jaap van der Laan, Ineke van Lijnschoten, Ariadne H. A. G. Ooms, Lindsey Oudijk, Rachel S. van der Post, Mihaela G. Raicu, Bert Timmer, Myrtle J. van der Wel, Sybren L. Meijer   +17 more
wiley   +1 more source

Multidisciplinary Treatment for Esophagogastric Junction Cancer From a Dutch Perspective

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1404-1418, September 2026.
ABSTRACT Esophagogastric junction (EGJ) cancer is an increasing health burden worldwide. Over the past decade, significant advancements in centralization, multimodal treatment strategies, as well as the widespread adoption of minimally invasive surgical techniques, have led to marked improvements in perioperative outcomes and overall survival of EGJ ...
Hidde C. G. Overtoom, Suzanne S. Gisbertz   +1 more
wiley   +1 more source

Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett’s Esophagus

Gut and Liver, 2017
Background/AimsThe aim of this study was to investigate the associations between obesity and erosive esophagitis (EE) or Barrett’s esophagus (BE) in a Chinese population.Methods : Data from subjects were retrospectively collected from 2006 to 2009 ...
Shou-Wu Lee, Han-Chung Lien, Teng-Yu Lee, Chun-Fang Tung, Hong-Zen Yeh, Chi-Sen Chang   +5 more
doaj   +1 more source

Intestinal Metaplasia of the Distal Esophagus in a Patient With Untreated Achalasia—An Unusual Case and Review of Literature

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Barrett's esophagus (BE) and achalasia are distinct esophageal disorders with opposing pathophysiologic mechanisms, making their coexistence exceedingly rare. We describe a 51‐year‐old woman who presented with progressive dysphagia, postprandial vomiting, and significant weight loss over 8 months.
Rohan Karkra, Mahinaz Mohsen, Salil Chowdhury, Kaveh Hajifathalian, Ahmed Al‐Khazraji   +4 more
wiley   +1 more source

Diagnosis and Management of Barrett’s Esophagus, Dysplasia and Early Esophageal Adenocarcinoma: Focusing on American and European Guidelines

The Korean Journal of Gastroenterology, 2019
Barrett’s esophagus (BE) is one of the most prominent diseases in Western countries because of its potential to progress to dysplasia or adenocarcinoma. Recently, the American College of Gastroenterology (ACG), American Gastroenterology Association (AGA),
Ah Young Yoo, Moon Kyung Joo
doaj   +1 more source

Alcohol exposure promotes cell communication network 1 cleavage in esophageal adenocarcinoma cells exclusively

Journal of Cell Communication and Signaling, Volume 20, Issue 3, September 2026.
An illustration shows how cell communication network 1 (CCN1) is involved in the normal esophagus, esophageal squamous cell carcinoma (ESCC), and esophageal adenocarcinoma (EAC) after alcohol exposure. Alcohol exposure upregulates CCN1 expression in the esophageal epithelium, with or without esophageal cancer. In normal individuals, CCN1 repairs tissue
Wula Aladan, Baoxin Chi, Zhiheng Chang, Mizhu Wang, Tong Dang, Xianmei Meng, Jianyuan Chai   +6 more
wiley   +1 more source

Histopathology of Barrett esophagus

, 2011
Barrett esophagus (BE) is a metaplastic, premalignant lesion of the tubular esophagus that carries significant implications and is associated with approximately 0.5% annual cancer incidence.
Elizabeth A. Montgomery, Montgomery, Elizabeth A, Lysandra Voltaggio, Voltaggio, Lysandra   +3 more
core   +1 more source

O critério de positividade para a análise imunoistoquímica da p53 na confirmação da displasia do esôfago de Barrett faz diferença? Does positive criterium for p53 immunohistochemical analysis in the confirmation of Barrett's dysplasia make difference?

Arquivos de Gastroenterologia, 2005
RACIONAL: O esôfago de Barrett é uma complicação da doença do refluxo gastroesofágico com importante potencial de malignização. Relata-se que a expressão do marcador tumoral p53 se acentua com a progressão displasia-adenocarcinoma.
César Vivian Lopes, Júlio C. Pereira-Lima, Antônio Atalíbio Hartmann, Eunice Tonelotto, Karina Salgado   +4 more
doaj   +1 more source

Understanding the Epigenetic Landscape of Barrett's Esophagus and Esophageal Cancer: A Review of Current Findings, Caveats and Future Directions

Genes, Chromosomes and Cancer, Volume 65, Issue 9, September 2026.
ABSTRACT Esophageal cancer (OC) is currently the eighth most common form of cancer worldwide with a 5‐year survival rate of 10%–20%, with the primary risk factor of esophageal adenocarcinoma (OAC) being the development of Barrett's Esophagus (BO).
Louise Lawless, Trevor Doherty, Carla Surlis, Niamh Gilmartin, Therese M. Murphy   +4 more
wiley   +1 more source